Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
GKB Ophthalmics Ltd (GKB) is currently trading at 60.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
GKB Ophthalmics specializes in manufacturing and exporting unfinished ophthalmic lenses from Goa, India. The company has robust production capabilities with an installed capacity of 3 million lenses per annum. A strategic move was establishing a subsidiary in Germany, aiding market expansion into Europe. GKB started producing CR 39 lenses in 2007, indicating product line diversification. Recent ventures into producing Hi-Index lenses faced financial challenges, prompting reconsideration of expansion strategies.
Over the past 52 weeks, GKB Ophthalmics Ltd has traded between a low of ₹45.25 and a high of ₹91.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
GKB Ophthalmics Ltd has a market capitalization of approximately 29.77. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
GKB Ophthalmics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the FMCG sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 29.77 Cr, GKB Ophthalmics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
GKB Ophthalmics Ltd operates in the FMCG sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of GKB Ophthalmics Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
56.15 | 134 Cr | — | 2.00 | 0.00 | -22.68 | -23.46 | -98.51 | |
116.10 | 111 Cr | — | 3.58 | 0.00 | -3.41 | -3.28 | -13.20 | |
10.48 | 91 Cr | — | 0.51 | 0.00 | -2.92 | -3.49 | -2.57 | |
58.70 | 30 Cr | — | 0.57 | 0.00 | -9.50 | -2.61 | -1.58 | |
31.21 | 19 Cr | 222.93 | 1.70 | 0.00 | 0.29 | 1.29 | 0.22 | |
36.94 | 18 Cr | 217.29 | 0.88 | 0.00 | 0.34 | 6.21 | 0.20 | |
10.50 | 11 Cr | 10.82 | 1.98 | 0.00 | 22.49 | 25.39 | 15.75 |
Financial Results
GKB Ophthalmics reported unaudited standalone results for quarter and nine months ended Dec 31, 2025: Q3 revenue Rs.436.10 lakhs, total income Rs.790.22 lakhs, Q3 PAT Rs.98.08 lakhs; 9M PAT loss Rs.168.48 lakhs; results reviewed and approved by board (12 Feb 2026).
Board Meeting Outcome
Board approved unaudited standalone and consolidated results for quarter and nine months ended Dec 31, 2025 (with limited review); noted Labour Tribunal recovery order of Rs.8.82 crore to be contested and receipt of ~Rs.12.33 crore from liquidating subsidiary GSV.
Bearish
4
Neutral
5
Bullish
5
Bearish
9
Neutral
5
Bullish
32
Bearish
5
Neutral
0
Bullish
27
GKB Ophthalmics specializes in manufacturing and exporting unfinished ophthalmic lenses from Goa, India.
The company has robust production capabilities with an installed capacity of 3 million lenses per annum.
A strategic move was establishing a subsidiary in Germany, aiding market expansion into Europe.
GKB started producing CR 39 lenses in 2007, indicating product line diversification.
Recent ventures into producing Hi-Index lenses faced financial challenges, prompting reconsideration of expansion strategies.
FMCG
Personal Care - Indian - Medium / Small
30 Cr
Low Risk
—
156.2
—
0.6
91.70
45.25
Sales CAGR
Profit CAGR
ROE
ROCE
